Evidence for the butyrate metabolism as key pathway improving ulcerative colitis in both pediatric and adult patients.
Evidence for the butyrate metabolism as key pathway improving ulcerative colitis in both pediatric and adult patients.
复制标题
丁酸盐代谢是改善儿童和成人溃疡性结肠炎的关键途径的证据。
DOI:
10.1080/21655979.2021.1985815
复制
发表时间:
2021-12
期刊:
影响因子:
4.9
通讯作者:
Li M
中科院分区:
文献类型:
--
作者:
Zhou Z;Cao J;Liu X;Li M
Accumulating evidence has shown many similarities and differences of gene profiles and pathways between pediatric and adult ulcerative colitis (UC) patients. In this study, we aimed to investigate the shared genes and pathways in intestinal tissues of pediatric and adult UC. Differentially expressed genes (DEGs) between pediatric and adult UC were identified via bioinformatic analysis of Gene Expression Omnibus datasets GSE87473 and GSE126124. Gene Ontology and pathway enrichment were used to analyze overlapped and distinguished DEGs. Gene Set Variation Analysis (GSVA) was utilized for contrast consistency. Mice colitis models were induced by dextran sulfate sodium (DSS) and Citrobacter rodentium. 2616 DEGs were screened out in intestinal tissues of adult UC compared with those of adult healthy controls, and 1195 DEGs in pediatrics. Same pathways between pediatric and adult UC were enriched using overlapped DEGs, mainly related to immune responses and metabolic processes, including butyrate metabolism, which was also identified by GSVA analysis. Of note, butyrate metabolism was the exclusive down-regulated pathway enriched by these two analyses, indicating that butyrate metabolism is one of the key pathways associated with both pediatric and adult UC. In addition, butyrate suppressed DSS-induced and Citrobacter rodentium-induced intestinal inflammation in mice. Therefore, the study revealed that butyrate metabolism was critical in both pediatric and adult UC. And butyrate suppressed colitis in mice, which provided a theoretical basis for the potential treatment of butyrate for UC patients. Abbreviations: UC, Ulcerative colitis; IBD, Inflammatory bowel disease; DEGs, Differentially expressed genes; GEO, Gene Expression Omnibus; SVA, Spatial variant apodization; LIMMA, Linear models for the microarray data; FC, Fold change; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; GSVA, Gene Set Variation Analysis; MSigDB, Molecular Signatures Database; WT, Wild-type; DSS, Dextran sulfate sodium; HC, Healthy control; SD, Standard deviation; SNHG5, Small nucleolar RNA host gene 5; GLP-2, Glucagon-like peptide 2; GSE, Gene set enrichment; ECM, Extracellular matrix; TCA, Tricarboxylic acid cycle; NA, Not available.
登录
查看更多内容
影响因子:
8
作者:
Harbord, Marcus;Eliakim, Rami;Carbonnel, Franck
通讯作者:
Carbonnel, Franck
影响因子:
35.7
作者:
Alatab, Sudabeh;Sepanlou, Sadaf G.;Naghavi, Mohsen
通讯作者:
Naghavi, Mohsen
影响因子:
8.8
作者:
Chakrabarty S;Varghese VK;Sahu P;Jayaram P;Shivakumar BM;Pai CG;Satyamoorthy K
通讯作者:
Satyamoorthy K
影响因子:
4.9
作者:
Li D;Yang Y;Yin X;Liu Y;Xu H;Ni Y;Hang P;Niu S;Zhang H;Ding W;Kuang H
通讯作者:
Kuang H
DOI:
10.1097/mpg.0000000000001898
发表时间:
2018-07-01
影响因子:
2.9
作者:
Li, Katherine;Strauss, Richard;Friedman, Joshua R.
通讯作者:
Friedman, Joshua R.